<DOC>
	<DOCNO>NCT02767024</DOCNO>
	<brief_summary>Single center , prospective , randomize , non-blinded research study compare intravenous vasodilator infusion vs. inotropic infusion patient admit hospital emergency room Montefiore Medical Center present diagnosis acute decompensated systolic heart failure low cardiac output hypotensive .</brief_summary>
	<brief_title>Intravenous Vasodilator vs. Inotropic Therapy Patients With Heart Failure Reduced Ejection Fraction Acute Decompensation With Low Cardiac Output ( PRIORITY-ADHF Study )</brief_title>
	<detailed_description>The objective study determine administration diuretic intravenous sodium nitroprusside ( vasodilator therapy ) comparison intravenous dobutamine ( inotropic therapy ) lead reduction primary secondary endpoint patient acute decompensated systolic heart failure low cardiac output hypotensive .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiac Output , Low</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<mesh_term>Dobutamine</mesh_term>
	<mesh_term>Nitroprusside</mesh_term>
	<mesh_term>Vasodilator Agents</mesh_term>
	<criteria>History heart failure reduce ejection fraction ( HFrEF ) , New York Heart Association ( NYHA ) class IV know leave ventricular ejection fraction ( LVEF ) ≤ 40 % within last 6 month follow image technique : echocardiogram , radionuclear stress test , ventriculogram cardiac magnetic resonance imaging ( CMR ) perform within 6 month . Hospitalized present emergency department acute decompensated heart failure ( ADHF ) anticipate requirement intravenous ( IV ) therapy ( include IV diuretic ) . ADHF define include follow measured time presentation ( include emergency department ) end screening : 1 . Persistent dyspnea orthopnea edema screen time randomization , despite standard background therapy heart failure . 2 . Pulmonary congestion chest radiograph . 3 . Nterminal pro btype natriuretic peptide ( NTproBNP ) ≥ 2000 pg/ml ; patient ≥ 75 year old current atrial fibrillation , NTproBNP ≥ 3000 pg/ml . Clinical suspicious low cardiac output state ; consider presence follow sign symptoms hypoperfusion : narrow pulse pressure , cold extremity , mental obtundation , decline renal function , and/or low serum sodium . Systolic blood pressure ( SBP ) measure ≥ 90 &lt; 120 mmHg start end screening , without use intravenous vasopressor therapy . Hemodynamic criterion : CI ≤ 2.2 L·min−1·m−2 base CO calculate Fick formula PCWP ≥ 20 mmHg measure right heart catheterization time enrollment confirm SwanGanz measurement upon arrival Cardiac Care Unit ( CCU ) . Able randomized within first 24 hour presentation hospital , include emergency department . Clinical evidence acute coronary syndrome ( ACS ) currently within 30 day prior enrollment . ( Note diagnosis ACS clinical diagnosis sole presence elevate troponin concentration sufficient diagnosis ACS ) . Significant , uncorrected leave ventricular outflow track obstruction , u obstructive cardiomyopathy severe aortic stenosis ( i.e . aortic valve area &lt; 1.0 cm2 mean gradient &gt; 40 mmHg prior current echocardiogram ) . Severe mitral stenosis . Severe aortic insufficiency severe mitral regurgitation surgical percutaneous intervention indicate . Documented , prior time randomization , restrictive amyloid myocardiopathy acute myocarditis hypertrophic obstructive , restrictive constrictive cardiomyopathy ( include restrictive mitral filling pattern see Doppler echocardiographic assessment diastolic function ) . Complex congenital heart disease . Significant arrhythmia , include follow : sustain ventricular tachycardia ; atrial fibrillation atrial flutter sustain heart rate &gt; 130 beat per minute . Bradycardia sustain ventricular rate &lt; 45 beat per minute . Temperature &gt; 38.5°C ( oral equivalent ) sepsis active infection require IV antimicrobial treatment . History malignancy ( localize basal cell carcinoma skin ) , treat untreated terminal illness ( heart failure ) current life expectancy less year . Major surgery major neurologic event include cerebrovascular event , within 30 day prior enrollment . Need mechanical circulatory support ( MCS ) , include intraaortic balloon pump , Extracorporeal Membrane Oxygenation ( ECMO ) ventricular assist device . Need mechanical ventilatory support ( endotracheal intubation mechanical ventilation ) . Patient chronic heart failure inotropicdepended . Current ( within 2 hour prior screen ) treatment IV vasoactive therapy , include vasodilator , inotropic agent vasopressor . Patients severe renal impairment define prerandomization estimate Glomerular Filtration Rate ( eGFR ) &lt; 25 ml/min/1.73m2 calculate use simplify Modification Diet Renal Disease ( sMDRD ) equalization and/or receive current plan dialysis ultrafiltration . Patients acute kidney injury define increase serum creatinine 3 time baseline , reduction urine output &lt; 0.3 mL/kg per hour ≥12 hour , anuria ≥12 hour , patient undergoing renal replacement therapy . Patients Child C cirrhosis history cirrhosis evidence portal hypertension varix . Patients acute liver failure serum transaminase : aspartate transaminase ( AST ) and/or alanine transaminase ( ALT ) &gt; 3 time upper limit normal . Any major solid organ transplant recipient planned/anticipated organ transplant within 1 year . Patients hematocrit &lt; 25 % , history blood transfusion within 14 day prior screen , active lifethreatening gastrointestinal bleeding . Pregnant nursing ( lactate ) woman , pregnancy define state female conception termination gestation , confirm positive human chorionic gonadotropin ( hCG ) laboratory test . . History hypersensitive dobutamine sodium nitroprusside . Inability follow instruction comply followup procedure . Any medical condition ( ) investigator deem unsuitable study , include drug alcohol use psychiatric , behavioral cognitive disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>